Monday, December 23, 2024
HomeTagsLyvgen Biopharma

Lyvgen Biopharma

Lyvgen Announces Phase 2 Clinical Collaboration with Bristol Myers Squibb to Evaluate LVGN7409

Lyvgen Biopharma, a leading innovative global biotech company dedicated to discovering, developing and commercializing first-in-class and best-in-class biotherapeutics for cancer, announced an open label,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics